IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MALAGOLA, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.428
AS - Asia 13.319
EU - Europa 10.148
SA - Sud America 2.743
Continente sconosciuto - Info sul continente non disponibili 1.084
AF - Africa 301
OC - Oceania 31
Totale 53.054
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.733
SG - Singapore 4.646
CN - Cina 4.239
UA - Ucraina 2.369
BR - Brasile 2.222
IT - Italia 1.739
HK - Hong Kong 1.473
DE - Germania 1.405
VN - Vietnam 891
PL - Polonia 873
FI - Finlandia 807
FR - Francia 665
GB - Regno Unito 554
RU - Federazione Russa 510
BD - Bangladesh 498
TR - Turchia 487
IE - Irlanda 405
IN - India 376
CA - Canada 307
SE - Svezia 299
AR - Argentina 179
MX - Messico 134
IQ - Iraq 116
NL - Olanda 102
ZA - Sudafrica 99
EC - Ecuador 88
ES - Italia 83
ID - Indonesia 78
CO - Colombia 77
JP - Giappone 67
CZ - Repubblica Ceca 65
SA - Arabia Saudita 59
VE - Venezuela 56
AT - Austria 54
PK - Pakistan 49
IL - Israele 48
BE - Belgio 45
UZ - Uzbekistan 45
JM - Giamaica 39
PY - Paraguay 39
MA - Marocco 36
JO - Giordania 31
CR - Costa Rica 30
AU - Australia 29
AE - Emirati Arabi Uniti 26
LT - Lituania 26
TT - Trinidad e Tobago 26
HN - Honduras 25
KE - Kenya 25
SV - El Salvador 25
EG - Egitto 24
NG - Nigeria 24
CL - Cile 23
PE - Perù 23
MY - Malesia 21
EU - Europa 20
GT - Guatemala 20
UY - Uruguay 20
NI - Nicaragua 19
DZ - Algeria 17
PH - Filippine 17
TH - Thailandia 17
KZ - Kazakistan 16
NP - Nepal 16
DK - Danimarca 15
DO - Repubblica Dominicana 15
PT - Portogallo 15
AZ - Azerbaigian 14
GR - Grecia 14
IR - Iran 14
MU - Mauritius 14
PR - Porto Rico 14
TN - Tunisia 14
ET - Etiopia 13
SC - Seychelles 13
CH - Svizzera 12
OM - Oman 12
BO - Bolivia 11
PA - Panama 11
CW - ???statistics.table.value.countryCode.CW??? 10
MD - Moldavia 10
AL - Albania 9
BB - Barbados 9
BG - Bulgaria 9
EE - Estonia 9
KG - Kirghizistan 9
PS - Palestinian Territory 9
SN - Senegal 9
GP - Guadalupe 8
HU - Ungheria 8
KR - Corea 8
RO - Romania 8
BA - Bosnia-Erzegovina 7
RS - Serbia 7
AM - Armenia 6
LB - Libano 6
LK - Sri Lanka 5
LV - Lettonia 5
HR - Croazia 4
KW - Kuwait 4
Totale 51.936
Salva come PNG Salva come JPEG
Città #
Ashburn 2.383
Singapore 2.365
Woodbridge 2.002
Jacksonville 1.620
San Jose 1.572
Fairfield 1.567
Hong Kong 1.467
Houston 1.350
Council Bluffs 1.233
Ann Arbor 1.125
Warsaw 851
The Dalles 776
Princeton 737
Cambridge 735
Wilmington 732
Beijing 687
Seattle 640
Chandler 630
New York 595
Nanjing 539
Los Angeles 419
Helsinki 412
Dublin 390
Lauterbourg 389
Istanbul 353
Dallas 342
Columbus 310
Ho Chi Minh City 286
Munich 271
Brescia 260
Des Moines 256
São Paulo 241
Nanchang 233
Milan 203
Santa Clara 191
Hanoi 186
Buffalo 175
Changsha 150
Moscow 149
Redondo Beach 143
Shanghai 138
Tianjin 131
San Francisco 130
Jinan 129
Chicago 126
Shenyang 123
Hebei 118
San Diego 113
Dearborn 110
Rome 101
Orem 93
Toronto 92
Boardman 90
Phoenix 89
Turku 89
Hangzhou 87
Jiaxing 86
Brooklyn 79
London 77
Atlanta 68
Kunming 67
Denver 66
Kocaeli 64
Nuremberg 62
Frankfurt am Main 61
Verona 60
Guangzhou 58
Chennai 57
Rio de Janeiro 57
Brasília 56
Tokyo 56
Montreal 55
Ningbo 55
Zhengzhou 53
Johannesburg 51
Brno 50
Regensburg 50
Mexico City 47
Belo Horizonte 46
Boston 46
Brussels 45
Curitiba 44
North Bergen 44
Pune 43
Baghdad 39
Charlotte 39
Da Nang 39
Tashkent 39
Stockholm 36
Lanzhou 35
Biên Hòa 34
Amsterdam 33
Guayaquil 33
Manchester 31
Mumbai 31
Taizhou 30
Turin 30
Norwalk 29
Poplar 29
Paris 28
Totale 32.862
Salva come PNG Salva come JPEG
Nome #
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 337
Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis 326
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 305
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients 300
Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation 284
Zebrafish disease models in hematology: Highlights on biological and translational impact 255
Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia. 251
A specific Toll-like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation 223
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 216
Betaherpesvirus Reactivation and Toll-Like Receptor Expression After Allogeneic Stem Cell Transplantation. 213
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 213
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 209
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome 207
EXPRESSION OF TOLL-LIKE RECEPTORS ON PERIPHERAL BLOOD CELLS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: ONGOING RESULTS OF A PROSPECTIVE STUDY. 206
Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway. 195
Low dose AraC for Myelodysplastic Syndromes: is it still a current therapy ?. 194
Profile of Toll-Like Receptors on Peripheral Blood Cells in Relation to Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation 192
Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF) 192
A Gene Panel NGS-Based Strategy for Genomic Characterization of Acute Myeloid Leukemias (AMLs) 191
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial 189
Advances in CMV Management: A Single Center Real-Life Experience 187
TARGETING HRASV12G EXPRESSION TO THE ZEBRAFISH EARLY HEMOGENIC PROGENITORS INDUCES A MYELOPROLIFERATIVE DISORDER BY REPRESSING THE NOTCH PATHWAY. 186
Acute graft-versus-host disease and expression of Toll-like receptors on peripheral blood cells after allogeneic stem cell transplantation 186
Expression of Toll-Like Receptors on Peripheral Blood Cells After Allogeneic Stem Cell Transplantation: Results of a Prospective Study. 185
Intermittent Imatinib (INTERIM) Treatment of Patients with Ph+ Chronic Myeloid Leukemia in Complete Cytogenetic Response: Cytogenetic and Molecular Data At One Year. 183
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 181
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 179
Ethical and legal issues in haematopoietic stem cells (HSC) donation: the controversial and problematic aspects in minors 179
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 178
Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms 177
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 176
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 175
Chitosan-Hydrogel Polymeric Scaffold Acts as an Independent Primary Inducer of Osteogenic Differentiation in Human Mesenchymal Stromal Cells 175
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review 174
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 174
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent 172
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients. 171
Allogeneic transplantation for patient with myelodisplastic sindromes: a single centre experience 170
Peripheral Blood WT1 Expression Predicts Relapse in AML Patients Undergoing Allogeneic Stem Cell Transplantation. 169
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 168
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation 167
5-azacitidine five days/monthly schedule in symptomatic low-risk (IPSS: 0-1) myelodisplastic (MDS) patients. clinical and biological effects. 166
Central nervous system angiitis in Hodgkin's disease. 165
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 165
Development of a cell culture model based on biocompatible polymeric scaffolds engineered with human Mesenchymal Stromal Cells (MSCs) for cartilage and bone regenerative therapy 165
Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia. 164
Single Cell Analysis of Circulating Endothelial Cells in Allogeneic Hematopoietic Stem Cell Transplant; To Whom Do They Belong: Host or Donor? 164
Is the New Tci Score Sufficient to Categorize the Intensity of Conditioning? a Single-Centre Study 163
MULTI-GENOTYPING OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) IN ALLOGENEIC STEM CELL TRANSPLANTATION AND THEIR ROLE IN DETERMINING GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECT. 163
Liposomal doxorubicin for the treatment of iatrogenic kaposi sarcoma following hematopoietic stem cell transplantation 163
Targeting oncogene expression to endothelial cells induces proliferation of the myelo-erythroid lineage by repressing the notch pathway. 162
Molecular and cytogenetic characterization of a new case of t(5;17)(q35;q21) variant acute promyelocytic leukemia 161
Assessment of Liver Damage with Transient Hepatic Elastography (FIBROSCAN) in patients with chronic Graft-Versus-Host Disease. 161
Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target? 161
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 161
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey. 161
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 160
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia 159
Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment 159
CT-290: Clinical Frailty Scale as a Novel Tool to Evaluate Patients’ Eligibility for Allogeneic Stem Cell Transplant: A Single-Center Experience on 234 Patients >50 Years Old 159
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. 158
PARAMETERS OF PROTEIN METABOLISM AND THYROID FUNCTION AS PREDICTORS OF A SCORING SYSTEM FOR ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE 158
Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing 158
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 158
Second chronic phase before transplantation is crucial for improving survival of blastic phase chronic myeloid leukaemia. 156
TOLL-LIKE RECEPTORS ON PERIPHERAL BLOOD CELLS AND ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: RESULTS OF A PROSPECTIVE STUDY 156
First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response 156
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 153
Real time quantification of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate arisk for clinical relapse and may identify patients in curable state 152
Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia 152
Advances in the treatment of monoclonal gammapathies: the emerging role of targeted therapy in plasma cell dyscrasias. 151
A NEW PROMISING APPROACH TO PERFORM HLA TYPING IN A QUICKLY, SIMPLE AND ACCURATE WAY: THE PYROSEQUENCING 151
Urinary Protein Levels in Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) Predict Severe Disease Related Complications at Myeloma Progression 151
Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML) 151
ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience 151
Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients. 150
P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY 149
Acute myeloid leukemia in the elderly: results obtained with conventional chemotherapy 149
Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients 149
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients. 148
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA 147
ANTI-CMV IMMUNOGLOBULINS IN ASSOCIATION WITH ANTI-CMV DRUGS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES SUBMITTED TO ALLOGENEIC STEM CELL TRANSPLANTATION: A MULTI-CENTRE RETROSPECTIVE EXPERIENCE 147
Tyrosine kinase inhibitors in Ph+ acute lymphoblastic leukaemia: facts and perspectives 146
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 146
3-YEARS and Beyond Study Completion Results of the Otpkima Randomized Clinical Trial in Elderly CML Patients 145
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases 145
Nutritional intervention with TGF-beta enriched food for special medical purposes (TGF-FSMP) is associated with a reduction of malnutrition, acute GVHD, pneumonia and may improve overall survival in patients undergoing allogeneic hematopoietic stem transplantation 144
WT1 Monitoring of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia. 144
AIDA: The italian way of treating acute promyelocytic leukemia (APL): final act . 144
Successful hematopoietic stem cell transplantation for complete CTLA-4 haploinsufficiency due to a de novo monoallelic 2q33.2-2q33.3 deletion 144
Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-kit positive acute myeloid leukemia. Results of an italian multicentric phase II study. 143
ACHIEVEMENT OF COMPLETE REMISSION WITH PONATINIB THERAPY FOR PHILADELPHIA ACUTE LYMPHOBLASTIC LEUKEMIA RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: A CASE REPORT. 143
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 143
Achievement of complete remission with Ponatinib therapy for Philadelphia positive acute lymphoblastic leukemia relapsed after allogeneic stem cell transplantation: a case report 143
Long Term Follow-up of Ph+ CML Patients Achieving Complete Cytogenetic Response (CCgR) with Interferon Based Therapy - GIMEMA Protocol CML0509. 142
Autologous Stem Cell Transplantation before Lymphocyte Apheresis for CAR-T Cells Therapy Negatively Impacts on T-Cells Fitness and NK Cell Levels in DLBCL Patients 141
Prompt resolution of nasal aspergillosis with intranasal instillation of liposomal amphotericin-B (amBisome) and granulocyte transfusions 141
Pre-Emptive Donor Lymphocyte Infusion As Optimal Treatment for Relapsed Acute Myeloid Leukemias and Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation: Insights from a French-Italian Study on 134 Patients 140
Expression of Toll-like receptors on peripheral blood cells after allogeneic stem cell transplantation: ongoing results of a prospective study. 140
Platelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary disease. 140
Totale 17.417
Salva come PNG Salva come JPEG
Categoria #
all - tutte 257.445
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 257.445
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.918 0 0 0 0 111 203 128 194 141 365 203 573
2022/20232.153 435 45 53 175 162 597 7 199 259 30 91 100
2023/20242.723 125 72 190 140 130 457 122 93 758 32 40 564
2024/20256.853 62 79 68 775 775 559 640 200 896 446 1.300 1.053
2025/202615.786 1.265 2.060 1.266 2.309 1.273 1.189 2.310 699 979 1.356 600 480
2026/20275.469 769 722 1.309 2.381 288 0 0 0 0 0 0 0
Totale 53.054